Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Green-Pharm Co., Ltd. is a research-driven pharmaceutical company based in Beijing, China, specializing in the development of innovative small molecule therapeutics and high-end active pharmaceutical ingredients (APIs). Founded in 2004, the company has established an integrated platform that encompasses drug design, process chemistry, and large-scale GMP manufacturing. Green-Pharm's internal pipeline focuses on high-unmet-need areas, including oncology, cardiovascular diseases, and metabolic disorders, with several candidates in clinical and preclinical stages. In addition to its proprietary R&D, the company serves as a strategic CDMO partner for global pharmaceutical firms, providing specialized chemical synthesis and manufacturing solutions. With facilities in Beijing and Tianjin, Green-Pharm is positioned as a key player in the Chinese innovative drug landscape, leveraging its technical expertise to bridge the gap between laboratory discovery and commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green-Pharm.